Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria
Condition: Uncomplicated Plasmodium Falciparum Malaria Interventions: Drug: KAF156; Drug: LUM-SDF Sponsors: Novartis Pharmaceuticals; European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials